Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
Shulin Wei,Mingxing Li,Qin Wang,Yueshui Zhao,Fukuan Du,Yu Chen,Shuai Deng,Jing Shen,Ke Wu,Jiayue Yang,Yuhong Sun,Li Gu,Xiaobing Li,Wanping Li,Meijuan Chen,Xiao Ling,Lei Yu,Zhangang Xiao,Lishu Dong,Xu Wu
DOI: https://doi.org/10.2147/jir.s458103
IF: 4.5
2024-05-23
Journal of Inflammation Research
Abstract:Shulin Wei, 1, 2, &ast Mingxing Li, 1, 2, &ast Qin Wang, 1, 2, &ast Yueshui Zhao, 1, 2 Fukuan Du, 1, 2 Yu Chen, 1, 2 Shuai Deng, 1, 2 Jing Shen, 1, 2 Ke Wu, 1, 2 Jiayue Yang, 1, 2 Yuhong Sun, 1 Li Gu, 1 Xiaobing Li, 1 Wanping Li, 1 Meijuan Chen, 1 Xiao Ling, 3 Lei Yu, 3 Zhangang Xiao, 1, 2 Lishu Dong, 3 Xu Wu 1, 2 1 Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646100, People's Republic of China; 2 South Sichuan Institute of Translational Medicine, Luzhou, Sichuan, 646100, People's Republic of China; 3 Department of Obstetrics, Luzhou Maternal & Child Health Hospital (Luzhou Second People's Hospital), Luzhou, Sichuan, 646100, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lishu Dong, Department of Obstetrics, Luzhou Maternal & Child Health Hospital (Luzhou Second People's Hospital), Luzhou, Sichuan, 646100, People's Republic of China, Email Xu Wu, Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646100, People's Republic of China, Email Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract, which has a high recurrence rate and is incurable due to a lack of effective treatment. Mesenchymal stromal cells (MSCs) are a class of pluripotent stem cells that have recently received a lot of attention due to their strong self-renewal ability and immunomodulatory effects, and a large number of experimental and clinical models have confirmed the positive therapeutic effect of MSCs on IBD. In preclinical studies, MSC treatment for IBD relies on MSCs paracrine effects, cell-to-cell contact, and its mediated mitochondrial transfer for immune regulation. It also plays a therapeutic role in restoring the intestinal mucosal barrier through the homing effect, regulation of the intestinal microbiome, and repair of intestinal epithelial cells. In the latest clinical trials, the safety and efficacy of MSCs in the treatment of IBD have been confirmed by transfusion of autologous or allogeneic bone marrow, umbilical cord, and adipose MSCs, as well as their derived extracellular vesicles. However, regarding the stable and effective clinical use of MSCs, several concerns emerge, including the cell sources, clinical management (dose, route and frequency of administration, and pretreatment of MSCs) and adverse reactions. This article comprehensively summarizes the effects and mechanisms of MSCs in the treatment of IBD and its advantages over conventional drugs, as well as the latest clinical trial progress of MSCs in the treatment of IBD. The current challenges and future directions are also discussed. This review would add knowledge into the understanding of IBD treatment by applying MSCs. Keywords: mesenchymal stem cells, immunomodulation, inflammatory bowel disease, ulcerative colitis, Crohn's disease, cell therapy Mesenchymal stromal cells (MSCs) are a population of stromal cells capable of self-renewal and differentiation into various cell lineages given specific environmental cues. 1 MSCs can be extracted from various human tissues which is a pluripotent stem cell that are widely present in adult bone marrow and can differentiate into other cell types and related lineages of mesenchymal tissue. 2 MSCs differentiate into various cells at the single cell level in vitro including osteocytes, cartilage tissue cells, 3 cardiomyocytes 4 and epithelial cells. 5 The umbilical cord (including the Wharton's jelly, a gelatinous substance found inside the umbilical cord), 6,7 fetal tissue, 8 dental pulp 9 and placenta 10 have been investigated as sources of various MSCs types. Furthermore, the induced pluripotent stem cells (iPSCs) 11 have attracted much attention as a new source of MSCs, which are becoming an emerging cell therapy product. Due to their ability to self-renew, be pluripotent, and have immunomodulatory properties, MSCs are frequently utilized in adoptive cell therapy, tissue engineering, and regenerative medicine. 12,13 Of particular note, MSCs as an adoptive therapy exhibit vast potential in alleviating inflammation-related diseases including inflammatory bowel disease (IBD). Many clinical trials demonstrate b -Abstract Truncated-
immunology